Scala Biodesign
Develops computational protein design technologies for therapeutic and industrial applications
$16MSeries A
Role not disclosedTP
TLV Partners
Activity from announced rounds
Activity in this selectionAI · Series A
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $66M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionSlice Global Equity
Provides AI-native global equity compliance and management platform for multinational companies
$25MSeries A
Role not disclosedConverge Bio
AI platform for accelerated drug discovery and development
$25MSeries A
Role not disclosed